These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 830419)

  • 1. Differences in the responsiveness of splenic, lymph node, and peripheral blood lymphoid cells to tumor membrane extracts.
    Krueger JG; Segal RA; Moyer RC
    Cancer Res; 1977 Jan; 37(1):320-2. PubMed ID: 830419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-specific immune responsiveness of the tumor-bearing host.
    Burk MW; Yu S; McKhann CF
    Isr J Med Sci; 1976; 12(4-5):360-8. PubMed ID: 939694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ lymphoid cells of mouse mammary tumors. IV. Comparison of functional activity of lymphoid cells separated from mammary tumors to that of spleen and lymph node cells of tumor-sensitized mice.
    Ruppert B; Blazar B; Medina D; Heppner G
    J Immunol; 1979 Jun; 122(6):2180-3. PubMed ID: 448122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sera from tumor-bearing mice on mitogen and allogeneic cell stimulation of normal lymphoid cells.
    Whitney RB; Levy JG
    J Natl Cancer Inst; 1975 Mar; 54(3):733-41. PubMed ID: 123599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.
    Buessow SC; Paul RD; Lopez DM
    J Natl Cancer Inst; 1984 Jul; 73(1):249-55. PubMed ID: 6610791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the electrophoretic mobility of thymus, spleen and lymph node cells in tumor-bearing mice during dynamic tumor growth].
    Grinevich IuA; Fil'chakov FV; Alekseev SB; Kuz'menko AP
    Tsitologiia; 1989 Feb; 31(2):209-14. PubMed ID: 2734850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enumeration of polyclonal mitogen-responsive cells in different lymphoid tissues of the mouse.
    Doenhoff MJ; Janossy G; Kerbel RS
    Immunology; 1976 Mar; 30(3):367-78. PubMed ID: 1082851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the host lymphocyte subsets during chemical carcinogenesis.
    Brodt P; Lala PK
    Cancer Res; 1983 Sep; 43(9):4315-22. PubMed ID: 6871866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the mitogen response of lymphoid cells with progressive tumor growth.
    Gillette RW; Boone CW
    Cancer Res; 1975 Dec; 35(12):3774-9. PubMed ID: 1081429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
    Lopez PF; Parks WP; Lopez DM
    J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo generation of tumor-specific cytotoxic T-cells in the regional lymph node: effect of subcutaneous inoculation of mls-disparate spleen cells around implanted tumors in mice.
    Higasa M; Yamada K; Takagaki Y; Aoki M; Shinka S; Dohi Y
    Cancer Res; 1986 Oct; 46(10):4991-4. PubMed ID: 3489518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes.
    Janeway CA; Ron J; Katz ME
    J Immunol; 1987 Feb; 138(4):1051-5. PubMed ID: 3100626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular cytotoxicity in tumor-bearing mice after transfer of normal or tumor-sensitized lymphoid cells.
    Fisher B; Wolmark N; Saffer EA
    J Natl Cancer Inst; 1980 Dec; 65(6):1303-5. PubMed ID: 6933275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary in vitro lymphocyte-proliferative responses to syngeneic plasma cell tumors.
    Boyer PJ; Fahey JL
    Cancer Res; 1976 Apr; 36(4):1492-8. PubMed ID: 1083290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses.
    Watson GA; Lopez DM
    J Immunol; 1995 Sep; 155(6):3124-34. PubMed ID: 7673727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of normal T lymphocytes in tumor-bearing rats.
    Klobusická M; Koníková E
    Neoplasma; 1982; 29(6):727-34. PubMed ID: 6984490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-specific lymphocyte proliferative responses in inbred mice after Trichinella spiralis infection.
    Zhu DZ; Lu XF; Bell RG
    J Parasitol; 1990 Feb; 76(1):85-92. PubMed ID: 1688939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential responses of B cells from the spleen and lymph node to TNP-Ficoll.
    Goud SN; Muthusamy N; Subbarao B
    J Immunol; 1988 May; 140(9):2925-30. PubMed ID: 3129503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential function of dendritic cells isolated from blood and lymph nodes.
    Hill S; Coates JP; Kimber I; Knight SC
    Immunology; 1994 Oct; 83(2):295-301. PubMed ID: 7835950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.